PMID: 16514904Mar 7, 2006Paper

Diagnosis and prognosis of atheroembolic disease

Nefrología : publicación oficial de la Sociedad Española Nefrologia
A Rodríguez JornetM García García

Abstract

Atheroembolic disease is recognized as an iatrogenic complication from an invasive vascular procedure, such as manipulation of the aorta during angiography or vascular surgery, and after anticoagulant and fibrinolytic therapy. Cholesterol crystal embolism is caused by showers of cholesterol crystals from an atherosclerotic aorta that occlude small arteries. The kidney is a frequent target organ for cholesterol emboli because of proximity of the renal arteries to abdominal aorta and it receive an enormous amount of blood flows. We describe the epidemiologic agents of 19 cases that were diagnosed by histologic sections of the affected tissues; the eosinophilia and the renal failure are the clinical features that guide to the diagnosis, in patients with ischemic nephropathy and general atherosclerosis. 53% among patients had a previous invasive procedure and 26% occurred spontaneously. We remark the importance of the kidney's biopsy in diagnosis of the atheroembolic disease and their bad prognosis with 63% of death rate in 18 months of average follow-up. We report patients with the multiple cholesterol emboli syndrome mimicking systemic vasculitis: they died by multivisceral acute failure. The subacute presentation of atheroemboli...Continue Reading

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Francesco ScolariR Maiorca
Heart International
Chiara VenturelliFrancesco Scolari
Anales de medicina interna : organo oficial de la Sociedad Española de Medicina Interna
J M Cruz Vicente
Lancet
Francesco Scolari, Pietro Ravani
© 2021 Meta ULC. All rights reserved